"Designing Growth Strategies is in our DNA"

U.S. Normal Saline for Parenteral Use Market Size, Share & COVID-19 Impact Analysis, By Type (Plastic Bottles and Glass Bottles), By Application (Intramuscular Injection and Intravenous Infusion), and Country Forecast, 2023-2030

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI108892

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases, 2022
    2. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    3. Impact of COVID-19 on the Market
  5. U.S. Normal Saline for Parenteral Use Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Type
      1. Plastic Bottles
      2. Glass Bottles
    2. Market Analysis, Insights and Forecast – By Application
      1. Intramuscular Injection
      2. Intravenous Infusion
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Baxter
        1. Overview
        2. Product
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      2. B. Braun Melsungen AG
        1. Overview
        2. Product
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      3. Fresenius Kabi AG
        1. Overview
        2. Product
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      4. ICU Medical
        1. Overview
        2. Product
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      5. Otsuka Pharmaceutical Co., Ltd.
        1. Overview
        2. Product
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      6. Assure Infusions, Inc.
        1. Overview
        2. Product
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      7. EuroLife Healthcare Pvt. Ltd
        1. Overview
        2. Product
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      8. Grifols, S.A.
        1. Overview
        2. Product
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      9. Pfizer Inc
        1. Overview
        2. Product
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
Read Less

Table 01: U.S. Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Type, 2019-2030

Table 02: U.S. Normal Saline for Parenteral Use Market Volume (Units) Forecast, by Type, 2019-2030

Table 03: U.S. Normal Saline for Parenteral Use Market Revenue (USD billion) Forecast, by Application, 2019-2030

Table 04: U.S. Normal Saline for Parenteral Use Market Volume (Units) Forecast, by Application, 2019-2030

Figure 01: U.S. Normal Saline for Parenteral Use Market Revenue Breakdown (USD billion, %) by Type, 2022 & 2030

Figure 02: U.S. Normal Saline for Parenteral Use Market Value Share (%), by Type, 2022 & 2030

Figure 03: U.S. Normal Saline for Parenteral Use Market Value Share (%), by Application, 2022 & 2030

Figure 04: U.S. Normal Saline for Parenteral Use Market Share Analysis (%), By Company, 2022

U.S. Normal Saline for Parenteral Use Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 60
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports